首页 > 最新文献

Health Policy and Technology最新文献

英文 中文
Developing economic evaluation guidelines for the Kingdom of Saudi Arabia: Engagement of local experts 为沙特阿拉伯王国制定经济评价准则:当地专家的参与
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-06 DOI: 10.1016/j.hlpt.2025.101042
Fatma Maraiki , Tusneem Elhassan , Shouki Bazarbashi , Paul Scuffham , Haitham Tuffaha

Objectives

Economic evaluation has increased due to the emergence of national health technology assessment (HTA) agencies. This study aims to develop a country-specific guideline for conducting economic evaluation in the Kingdom of Saudi Arabia (KSA) as an HTA component to determine the value for money of new health interventions.

Methods

The study conducted a real-time Delphi survey using 17 items from the method component of the Consolidated Health Economic Evaluation Reporting Standards checklist as foundation for guidelines. Consensus was reached for the relevance of guideline recommendations for the KSA healthcare system. We set a threshold of 80 % for agreement and an interquartile range less than three on a nine-point Likert scale. Interim analysis provided feedback for recommendations of items if no consensus exists. A natural language processing (NLP) approach was employed to examine the relationship between experts’ comments and consensus decisions.

Results

The study recruited 78 % experts with an average response progress rate of 97.2 %. Interim analysis provided a 63 % adjustment rate for recommendations with the majority requiring further clarification (65 %). The guidelines concluded with a consensus on 76 % of recommendations, while four remained undetermined, namely, choice of discount rate, use of same rates for health benefits and costs, outcome selection, and gross costing. The NLP results supported the consensus decision.

Conclusions

Expert consensus contributed to the development of informative guidelines relevant to KSA. The guidelines serve as a reference case, thus providing a foundation for HTA practices, reimbursement decisions, and future research for the KSA and its neighboring countries.
目的随着国家卫生技术评价机构的出现,经济评价有所增加。本研究旨在制定一项针对具体国家的指导方针,以便在沙特阿拉伯王国(KSA)开展经济评估,作为卫生评估的一个组成部分,以确定新的卫生干预措施的物有所值。方法采用《综合卫生经济评价报告标准》方法部分的17个项目进行实时德尔菲调查,作为指导方针的基础。达成共识的相关性指南建议的KSA医疗保健系统。我们设定了80%的一致性阈值,在9分李克特量表上,四分位数范围小于3。如果没有协商一致意见,临时分析提供了对项目建议的反馈。采用自然语言处理(NLP)方法来检验专家意见与共识决策之间的关系。结果共招募专家78%,平均应答率97.2%。中期分析显示,建议的调整率为63%,大多数建议需要进一步澄清(65%)。最后,指南对76%的建议达成了共识,而四项建议仍未确定,即选择贴现率、使用相同的健康福利和成本率、结果选择和总成本计算。NLP结果支持共识决定。结论专家共识有助于制定与KSA相关的信息指南。该指南可作为参考案例,从而为卫生保健协会的实践、报销决策和沙特阿拉伯及其邻国的未来研究提供基础。
{"title":"Developing economic evaluation guidelines for the Kingdom of Saudi Arabia: Engagement of local experts","authors":"Fatma Maraiki ,&nbsp;Tusneem Elhassan ,&nbsp;Shouki Bazarbashi ,&nbsp;Paul Scuffham ,&nbsp;Haitham Tuffaha","doi":"10.1016/j.hlpt.2025.101042","DOIUrl":"10.1016/j.hlpt.2025.101042","url":null,"abstract":"<div><h3>Objectives</h3><div>Economic evaluation has increased due to the emergence of national health technology assessment (HTA) agencies. This study aims to develop a country-specific guideline for conducting economic evaluation in the Kingdom of Saudi Arabia (KSA) as an HTA component to determine the value for money of new health interventions.</div></div><div><h3>Methods</h3><div>The study conducted a real-time Delphi survey using 17 items from the method component of the Consolidated Health Economic Evaluation Reporting Standards checklist as foundation for guidelines. Consensus was reached for the relevance of guideline recommendations for the KSA healthcare system. We set a threshold of 80 % for agreement and an interquartile range less than three on a nine-point Likert scale. Interim analysis provided feedback for recommendations of items if <em>no consensus</em> exists. A natural language processing (NLP) approach was employed to examine the relationship between experts’ comments and consensus decisions.</div></div><div><h3>Results</h3><div>The study recruited 78 % experts with an average response progress rate of 97.2 %. Interim analysis provided a 63 % adjustment rate for recommendations with the majority requiring further clarification (65 %). The guidelines concluded with a consensus on 76 % of recommendations, while four remained undetermined, namely, choice of discount rate, use of same rates for health benefits and costs, outcome selection, and gross costing. The NLP results supported the consensus decision.</div></div><div><h3>Conclusions</h3><div>Expert consensus contributed to the development of informative guidelines relevant to KSA. The guidelines serve as a reference case, thus providing a foundation for HTA practices, reimbursement decisions, and future research for the KSA and its neighboring countries.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101042"},"PeriodicalIF":3.4,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144595833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI in personalized medicine: Bridging ethical and regulatory gaps in resource-limited settings 个性化医疗中的人工智能:在资源有限的环境中弥合伦理和监管差距
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-06 DOI: 10.1016/j.hlpt.2025.101052
Aliasgar Shahiwala
{"title":"AI in personalized medicine: Bridging ethical and regulatory gaps in resource-limited settings","authors":"Aliasgar Shahiwala","doi":"10.1016/j.hlpt.2025.101052","DOIUrl":"10.1016/j.hlpt.2025.101052","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101052"},"PeriodicalIF":3.4,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144271476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic decision system for ENT surgery waiting list prioritization using M-Score and TOPSIS methodology 基于M-Score和TOPSIS方法的耳鼻喉外科候诊名单优先排序动态决策系统
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-03 DOI: 10.1016/j.hlpt.2025.101036
Fabián Silva-Aravena, Jenny Morales
Objective: This study aims to develop and evaluate a dynamic prioritization system to improve surgical waiting list management for otorhinolaryngology (ENT) patients in a high-complexity public hospital in Chile. The proposed model aims to reduce waiting times and improve equity and clinical outcomes by dynamically incorporating changes in patient condition. Methods: We implemented a dynamic scoring system (M-Score), updated weekly using multidimensional biopsychosocial criteria, and integrated it with the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) to prioritize patients. The evaluation was carried out using Monte Carlo simulations over a 52-week horizon, simulating patient inflows and outflows via a balanced flow model. The stability and performance of the proposed model were compared with a static model and a traditional first-come, first-served (FCFS) protocol. Results: The proposed approach reduced the average waiting time from 130 to 91 days compared to the static model (a 30 % relative and absolute decrease of 39 days) and from 157 to 91 days compared to FCFS (a 42 % relative and absolute reduction of 66 days). The greatest improvements were observed among high-risk patients, whose prioritization was adapted in real time to worsening clinical conditions. Conclusions: Our adaptive prioritization model demonstrates significant improvements in waiting time management, particularly for clinically vulnerable patients. Although the findings support its feasibility, further prospective validation is necessary before clinical implementation. Future research should focus on real-time integration with electronic medical records, scalability between specialties, and evaluation of impacts on patient satisfaction and health outcomes. Lay Summary: ENT patients in public hospitals often face long waiting times that increase health risks. This study introduces a weekly update to the prioritization model using social and health factors of the patient. The system reduced average waiting times by up to 66 days in simulation. High-risk patients were prioritized as their conditions worsened. This approach offers a promising data-driven strategy for improving waitlist management and resource allocation in public healthcare.
目的:本研究旨在开发和评估动态优先排序系统,以改善智利一家高复杂性公立医院耳鼻喉科(ENT)患者的手术等待名单管理。提出的模型旨在通过动态结合患者病情的变化来减少等待时间,提高公平性和临床结果。方法:我们实施了一个动态评分系统(M-Score),每周更新一次,使用多维生物心理社会标准,并将其与理想解决方案相似性排序偏好技术(TOPSIS)相结合,对患者进行优先排序。评估使用蒙特卡罗模拟进行,为期52周,通过平衡流动模型模拟患者流入和流出。将该模型的稳定性和性能与静态模型和传统的先到先服务(FCFS)协议进行了比较。结果:与静态模型相比,该方法将平均等待时间从130天减少到91天(相对和绝对减少39天,减少30%),与FCFS相比,该方法将平均等待时间从157天减少到91天(相对和绝对减少66天,减少42%)。在高危患者中观察到最大的改善,他们的优先级实时适应恶化的临床状况。结论:我们的适应性优先排序模型显示了等待时间管理的显著改善,特别是对临床弱势患者。尽管研究结果支持其可行性,但在临床应用之前需要进一步的前瞻性验证。未来的研究应集中在与电子病历的实时集成、专科之间的可扩展性以及对患者满意度和健康结果影响的评估上。概要:公立医院的耳鼻喉科病人经常面临长时间的等待,这增加了健康风险。这项研究引入了每周更新的优先级模型,使用患者的社会和健康因素。在模拟中,该系统将平均等待时间缩短了66天。随着病情恶化,高危患者被优先考虑。这种方法为改善公共医疗保健的候补名单管理和资源分配提供了一种有前途的数据驱动策略。
{"title":"Dynamic decision system for ENT surgery waiting list prioritization using M-Score and TOPSIS methodology","authors":"Fabián Silva-Aravena,&nbsp;Jenny Morales","doi":"10.1016/j.hlpt.2025.101036","DOIUrl":"10.1016/j.hlpt.2025.101036","url":null,"abstract":"<div><div>Objective: This study aims to develop and evaluate a dynamic prioritization system to improve surgical waiting list management for otorhinolaryngology (ENT) patients in a high-complexity public hospital in Chile. The proposed model aims to reduce waiting times and improve equity and clinical outcomes by dynamically incorporating changes in patient condition. Methods: We implemented a dynamic scoring system (M-Score), updated weekly using multidimensional biopsychosocial criteria, and integrated it with the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) to prioritize patients. The evaluation was carried out using Monte Carlo simulations over a 52-week horizon, simulating patient inflows and outflows via a balanced flow model. The stability and performance of the proposed model were compared with a static model and a traditional first-come, first-served (FCFS) protocol. Results: The proposed approach reduced the average waiting time from 130 to 91 days compared to the static model (a 30 % relative and absolute decrease of 39 days) and from 157 to 91 days compared to FCFS (a 42 % relative and absolute reduction of 66 days). The greatest improvements were observed among high-risk patients, whose prioritization was adapted in real time to worsening clinical conditions. Conclusions: Our adaptive prioritization model demonstrates significant improvements in waiting time management, particularly for clinically vulnerable patients. Although the findings support its feasibility, further prospective validation is necessary before clinical implementation. Future research should focus on real-time integration with electronic medical records, scalability between specialties, and evaluation of impacts on patient satisfaction and health outcomes. Lay Summary: ENT patients in public hospitals often face long waiting times that increase health risks. This study introduces a weekly update to the prioritization model using social and health factors of the patient. The system reduced average waiting times by up to 66 days in simulation. High-risk patients were prioritized as their conditions worsened. This approach offers a promising data-driven strategy for improving waitlist management and resource allocation in public healthcare.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101036"},"PeriodicalIF":3.4,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144330586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spillover effects of pain medication tapering in chronic pain patients: a systematic review and consequences for health economic evaluation studies 慢性疼痛患者止痛药减量的溢出效应:健康经济评价研究的系统回顾和后果
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-02 DOI: 10.1016/j.hlpt.2025.101037
Frenn Bultinck , Nick Verhaeghe , Max Lelie , Bo Vandenbulcke , Elke Wuyts , Cleo L. Crunelle , Lisa Goudman , Maarten Moens , Koen Putman

Background

Spillover effects of pain medication tapering (PMT) programs in patients with chronic pain (CP) are underexplored. This systematic review presents current research on the study of spillover effects of PMT in patients with CP and provides suggestions for examination of spillover effects in health economic research of PMT. Understanding spillover effects enable wide-ranging assessment of interventions, including its broader impacts.

Methods

Literature was searched up to September 2023 in Web of Science, PubMed, Scopus, Embase, PsychINFO, APA PsychNet, Cochrane library, Econlit, and grey literature sources including Google Scholar, CADTH, Mednar and the WHO website. QualSyst was used for Risk of bias assessment. The study protocol was registered prospectively in PROSPERO (CRD42023461763). Results were classified into five domains and incorporated into the expanded impact inventory framework. No funding was obtained.

Results

Of 2099 records initially identified, six qualitative studies of varying quality were included. In the healthcare domain, additional demands on healthcare delivery, patients switching between healthcare providers and psychosocial impacts for healthcare providers were key findings. Scientific spillovers entailed evidence-based recommendations, enhanced PMT awareness and knowledge dissemination. Sociological effects encompassed bias affecting underrepresented groups and community-level benefits. No spillovers were found in other categories. Future research should extend beyond patient-centered outcomes to comprehensively assess PMT’s societal impact and reveal indirect benefits currently underrepresented in the literature.

Conclusions

Spillover effects of PMT in patients with CP were identified. Considering spillovers can allow policymakers to optimize healthcare policies and resource allocation in healthcare. Inclusion of only six studies is a limitation of this study.
背景:慢性疼痛(CP)患者的疼痛药物减量(PMT)计划的溢出效应尚未得到充分研究。本文系统综述了PMT对CP患者溢出效应的研究现状,并对PMT在健康经济学研究中的溢出效应研究提出了建议。了解溢出效应有助于对干预措施进行广泛评估,包括其更广泛的影响。方法在Web of Science、PubMed、Scopus、Embase、PsychINFO、APA PsychNet、Cochrane library、Econlit以及谷歌Scholar、CADTH、Mednar和WHO网站等灰色文献源中检索截至2023年9月的文献。使用QualSyst进行偏倚风险评估。该研究方案在PROSPERO中前瞻性注册(CRD42023461763)。结果被分为五个领域,并纳入扩大的影响清单框架。没有获得资金。结果在最初确定的2099份记录中,纳入了6份不同质量的定性研究。在医疗保健领域,对医疗保健服务的额外需求、患者在医疗保健提供者之间的转换以及对医疗保健提供者的心理社会影响是主要发现。科学溢出效应包括基于证据的建议、加强对PMT的认识和知识传播。社会学效应包括影响代表性不足群体和社区层面利益的偏见。其他类别没有发现溢出效应。未来的研究应超越以患者为中心的结果,全面评估PMT的社会影响,并揭示目前文献中未充分代表的间接益处。结论PMT在CP患者中的外溢效应是明确的。考虑溢出效应可以使决策者优化医疗保健政策和医疗保健资源配置。仅纳入6项研究是本研究的局限性。
{"title":"Spillover effects of pain medication tapering in chronic pain patients: a systematic review and consequences for health economic evaluation studies","authors":"Frenn Bultinck ,&nbsp;Nick Verhaeghe ,&nbsp;Max Lelie ,&nbsp;Bo Vandenbulcke ,&nbsp;Elke Wuyts ,&nbsp;Cleo L. Crunelle ,&nbsp;Lisa Goudman ,&nbsp;Maarten Moens ,&nbsp;Koen Putman","doi":"10.1016/j.hlpt.2025.101037","DOIUrl":"10.1016/j.hlpt.2025.101037","url":null,"abstract":"<div><h3>Background</h3><div>Spillover effects of pain medication tapering (PMT) programs in patients with chronic pain (CP) are underexplored. This systematic review presents current research on the study of spillover effects of PMT in patients with CP and provides suggestions for examination of spillover effects in health economic research of PMT. Understanding spillover effects enable wide-ranging assessment of interventions, including its broader impacts.</div></div><div><h3>Methods</h3><div>Literature was searched up to September 2023 in Web of Science, PubMed, Scopus, Embase, PsychINFO, APA PsychNet, Cochrane library, Econlit, and grey literature sources including Google Scholar, CADTH, Mednar and the WHO website. QualSyst was used for Risk of bias assessment. The study protocol was registered prospectively in PROSPERO (CRD42023461763). Results were classified into five domains and incorporated into the expanded impact inventory framework. No funding was obtained.</div></div><div><h3>Results</h3><div>Of 2099 records initially identified, six qualitative studies of varying quality were included. In the healthcare domain, additional demands on healthcare delivery, patients switching between healthcare providers and psychosocial impacts for healthcare providers were key findings. Scientific spillovers entailed evidence-based recommendations, enhanced PMT awareness and knowledge dissemination. Sociological effects encompassed bias affecting underrepresented groups and community-level benefits. No spillovers were found in other categories. Future research should extend beyond patient-centered outcomes to comprehensively assess PMT’s societal impact and reveal indirect benefits currently underrepresented in the literature.</div></div><div><h3>Conclusions</h3><div>Spillover effects of PMT in patients with CP were identified. Considering spillovers can allow policymakers to optimize healthcare policies and resource allocation in healthcare. Inclusion of only six studies is a limitation of this study.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101037"},"PeriodicalIF":3.4,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144254395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using ChatGPT in ethical dilemmas and policy-related complex decision making: Are we ready yet? 在伦理困境和政策相关的复杂决策中使用ChatGPT:我们准备好了吗?
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-05-30 DOI: 10.1016/j.hlpt.2025.101041
Orna Tal , Yaron Connelly

Background and Objective

Artificial intelligence (AI) algorithms using language models have emerged as valuable tools in medicine. While AI has demonstrated its ability to address clinical questions, its application in ethical dilemmas remains debated. Some argue that AI can synthesize diverse information to form a comprehensive perspective, while others caution against premature reliance. This study explored the potential of AI in addressing ethical medical dilemmas faced by physicians, transitioning from theoretical discussions to practical solutions.

Methods

ChatGPT-3.5 was presented with three socio-ethical dilemmas relevant to national health policy decisions, and its responses were compared to those of physicians and real-world decisions. The dilemmas included questions on (1) criteria for allocation of technologies when resources are limited (2) personalized treatment, and (3) conflicts between patient requests and health organizations' strategy.

Results

ChatGPT-3.5 aligned with physicians' views on budget allocation but diverged on age-related criteria. It struggled to resolve conflicts between patient preferences and organizational strategies. Its responses reflected physician paternalism and a private market perspective, emphasizing system-wide benefit (utilitarian approach), likely due to familiarity with private healthcare systems.

Conclusions

ChatGPT-3.5 demonstrated an evolving capacity to engage with complex medico-ethical dilemmas but also revealed biases and limitations. Policymakers must carefully integrate AI tools, incorporating broader economic and social insights while ensuring adaptability to diverse scenarios. The academic community and clinicians must remain vigilant and regulate the rapid implementation of AI in the increasingly uncertain and evolving healthcare landscape.
使用语言模型的人工智能(AI)算法已经成为医学中有价值的工具。虽然人工智能已经证明了它解决临床问题的能力,但它在伦理困境中的应用仍存在争议。一些人认为,人工智能可以综合各种信息,形成一个全面的视角,而另一些人则告诫不要过早依赖。本研究探讨了人工智能在解决医生面临的伦理医学困境方面的潜力,从理论讨论过渡到实际解决方案。方法提出了与国家卫生政策决策相关的三个社会伦理困境,并将其与医生和现实世界决策的反应进行了比较。这些困境包括以下问题:(1)资源有限时的技术分配标准;(2)个性化治疗;(3)患者要求与卫生组织策略之间的冲突。结果schatgpt -3.5与医生对预算分配的看法一致,但在与年龄相关的标准上存在分歧。它努力解决患者偏好和组织策略之间的冲突。它的反应反映了医生的家长式作风和私人市场的观点,强调系统范围的利益(功利主义方法),可能是由于对私人医疗保健系统的熟悉。结论:atgpt -3.5显示了处理复杂医学伦理困境的不断发展的能力,但也揭示了偏见和局限性。政策制定者必须仔细整合人工智能工具,在确保适应不同情景的同时,纳入更广泛的经济和社会见解。学术界和临床医生必须保持警惕,并在日益不确定和不断发展的医疗保健环境中规范人工智能的快速实施。
{"title":"Using ChatGPT in ethical dilemmas and policy-related complex decision making: Are we ready yet?","authors":"Orna Tal ,&nbsp;Yaron Connelly","doi":"10.1016/j.hlpt.2025.101041","DOIUrl":"10.1016/j.hlpt.2025.101041","url":null,"abstract":"<div><h3>Background and Objective</h3><div>Artificial intelligence (AI) algorithms using language models have emerged as valuable tools in medicine. While AI has demonstrated its ability to address clinical questions, its application in ethical dilemmas remains debated. Some argue that AI can synthesize diverse information to form a comprehensive perspective, while others caution against premature reliance. This study explored the potential of AI in addressing ethical medical dilemmas faced by physicians, transitioning from theoretical discussions to practical solutions.</div></div><div><h3>Methods</h3><div>ChatGPT-3.5 was presented with three socio-ethical dilemmas relevant to national health policy decisions, and its responses were compared to those of physicians and real-world decisions. The dilemmas included questions on (1) criteria for allocation of technologies when resources are limited (2) personalized treatment, and (3) conflicts between patient requests and health organizations' strategy.</div></div><div><h3>Results</h3><div>ChatGPT-3.5 aligned with physicians' views on budget allocation but diverged on age-related criteria. It struggled to resolve conflicts between patient preferences and organizational strategies. Its responses reflected physician paternalism and a private market perspective, emphasizing system-wide benefit (utilitarian approach), likely due to familiarity with private healthcare systems.</div></div><div><h3>Conclusions</h3><div>ChatGPT-3.5 demonstrated an evolving capacity to engage with complex medico-ethical dilemmas but also revealed biases and limitations. Policymakers must carefully integrate AI tools, incorporating broader economic and social insights while ensuring adaptability to diverse scenarios. The academic community and clinicians must remain vigilant and regulate the rapid implementation of AI in the increasingly uncertain and evolving healthcare landscape.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101041"},"PeriodicalIF":3.4,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144549377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring policy and regulations of clinical AI systems: Views from patients with chronic diseases 探讨临床人工智能系统的政策法规:来自慢性病患者的观点
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-05-29 DOI: 10.1016/j.hlpt.2025.101035
Bijun Wang , Onur Asan , Turki Alelyani
<div><h3>Background</h3><div>Artificial Intelligence (AI) has become a transformative force in healthcare, offering opportunities to enhance patient care, improve efficiency, and reduce costs. However, patients' perspectives, which greatly influence the acceptance and implementation of AI technologies, remain under-researched.</div></div><div><h3>Objective</h3><div>This study explores patients with chronic conditions’ perspectives on clinical AI systems, focusing on their concerns, government involvement, accountability for potential AI error, and preferences between AI and doctor recommendations. These insights are crucial for tailoring AI technologies to meet patients' needs and expectations and better engage patients in adopting new technologies.</div></div><div><h3>Method</h3><div>This study conducted an online open-ended survey with valid responses from 140 patients with chronic conditions, exploring four aspects of clinical AI perspectives. The data was systematically coded and analyzed using an inductive thematic analysis approach to identify emergent themes.</div></div><div><h3>Result</h3><div>The majority of participants expressed concerns about the implementation of AI in healthcare (92.86 %), with the top worries including lack of human touch (22.86 %), potential AI bias and fairness (16.43 %), and over-dependence on AI (16.43 %). Regarding responsibility for potential treatment damages, 37.14 % of participants believed that physicians should bear the responsibility, 16.43 % considered AI developers accountable, and 1.42 % viewed the government as the responsible party. Furthermore, 44.57 % suggested that responsibility should be shared among stakeholders. In terms of government role, 51.43 % saw regulation and monitoring as key responsibilities, while 8.57 % perceived no government role in AI healthcare. Finally, around 80 % of patients preferred treatment recommendations from care providers over AI.</div></div><div><h3>Conclusion</h3><div>The findings suggest patients are looking for a balanced approach between technology and human involvement, with clear accountability and proper regulation. Though most prefer human doctors, an openness to AI's potential indicates an evolving perception. This underscores the need for a governance-inclusive and patient-centric strategy that addresses these aspects to ensure successful AI integration in healthcare.</div></div><div><h3>Lay Summary</h3><div>This study explores the opinions of chronic patients on using AI in healthcare. It found that while patients appreciate the potential benefits of AI, they have concerns about losing the personal touch of human doctors, potential biases, and over-reliance on technology. They also believe that accountability for AI errors should be shared among doctors, developers, and the government. The findings highlight the need for careful integration of AI in healthcare, with clear regulations and a focus on patient safety to build trust and acceptance.</div></di
人工智能(AI)已成为医疗保健领域的变革力量,为加强患者护理、提高效率和降低成本提供了机会。然而,患者的观点对人工智能技术的接受和实施有很大影响,但仍未得到充分研究。本研究探讨慢性病患者对临床人工智能系统的看法,重点关注他们的担忧、政府参与、对潜在人工智能错误的问责,以及人工智能和医生建议之间的偏好。这些见解对于定制人工智能技术以满足患者的需求和期望以及更好地吸引患者采用新技术至关重要。方法对140例慢性疾病患者进行在线开放式问卷调查,从四个方面探讨临床人工智能的应用前景。使用归纳主题分析方法对数据进行系统编码和分析,以确定紧急主题。结果大多数受访者对人工智能在医疗领域的应用表示担忧(92.86%),其中最担心的是缺乏人情感(22.86%)、潜在的人工智能偏见和公平性(16.43%)和过度依赖人工智能(16.43%)。关于潜在治疗损害的责任,37.14%的参与者认为医生应该承担责任,16.43%的参与者认为人工智能开发者应该负责,1.42%的参与者认为政府应该负责。此外,44.57%的人认为利益相关者应该分担责任。在政府角色方面,51.43%的人认为监管和监督是主要职责,而8.57%的人认为政府在人工智能医疗中没有作用。最后,大约80%的患者更喜欢护理提供者的治疗建议,而不是人工智能。结论研究结果表明,患者正在寻找技术和人类参与之间的平衡方法,具有明确的责任和适当的监管。尽管大多数人更喜欢人类医生,但对人工智能潜力的开放态度表明了一种不断发展的看法。这突出表明,需要制定包容性治理和以患者为中心的战略,解决这些问题,以确保人工智能在医疗保健领域的成功整合。摘要本研究探讨慢性患者在医疗保健中使用人工智能的意见。研究发现,虽然患者欣赏人工智能的潜在好处,但他们担心失去人类医生的个人接触、潜在的偏见和对技术的过度依赖。他们还认为,人工智能错误的责任应该由医生、开发人员和政府共同承担。研究结果强调了将人工智能纳入医疗保健的必要性,需要制定明确的法规,并关注患者安全,以建立信任和接受度。
{"title":"Exploring policy and regulations of clinical AI systems: Views from patients with chronic diseases","authors":"Bijun Wang ,&nbsp;Onur Asan ,&nbsp;Turki Alelyani","doi":"10.1016/j.hlpt.2025.101035","DOIUrl":"10.1016/j.hlpt.2025.101035","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Artificial Intelligence (AI) has become a transformative force in healthcare, offering opportunities to enhance patient care, improve efficiency, and reduce costs. However, patients' perspectives, which greatly influence the acceptance and implementation of AI technologies, remain under-researched.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;This study explores patients with chronic conditions’ perspectives on clinical AI systems, focusing on their concerns, government involvement, accountability for potential AI error, and preferences between AI and doctor recommendations. These insights are crucial for tailoring AI technologies to meet patients' needs and expectations and better engage patients in adopting new technologies.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Method&lt;/h3&gt;&lt;div&gt;This study conducted an online open-ended survey with valid responses from 140 patients with chronic conditions, exploring four aspects of clinical AI perspectives. The data was systematically coded and analyzed using an inductive thematic analysis approach to identify emergent themes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Result&lt;/h3&gt;&lt;div&gt;The majority of participants expressed concerns about the implementation of AI in healthcare (92.86 %), with the top worries including lack of human touch (22.86 %), potential AI bias and fairness (16.43 %), and over-dependence on AI (16.43 %). Regarding responsibility for potential treatment damages, 37.14 % of participants believed that physicians should bear the responsibility, 16.43 % considered AI developers accountable, and 1.42 % viewed the government as the responsible party. Furthermore, 44.57 % suggested that responsibility should be shared among stakeholders. In terms of government role, 51.43 % saw regulation and monitoring as key responsibilities, while 8.57 % perceived no government role in AI healthcare. Finally, around 80 % of patients preferred treatment recommendations from care providers over AI.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;The findings suggest patients are looking for a balanced approach between technology and human involvement, with clear accountability and proper regulation. Though most prefer human doctors, an openness to AI's potential indicates an evolving perception. This underscores the need for a governance-inclusive and patient-centric strategy that addresses these aspects to ensure successful AI integration in healthcare.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Lay Summary&lt;/h3&gt;&lt;div&gt;This study explores the opinions of chronic patients on using AI in healthcare. It found that while patients appreciate the potential benefits of AI, they have concerns about losing the personal touch of human doctors, potential biases, and over-reliance on technology. They also believe that accountability for AI errors should be shared among doctors, developers, and the government. The findings highlight the need for careful integration of AI in healthcare, with clear regulations and a focus on patient safety to build trust and acceptance.&lt;/div&gt;&lt;/di","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101035"},"PeriodicalIF":3.4,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144212819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health equity in the digital age: Exploring health policy and inclusive digital care 数字时代的卫生公平:探索卫生政策和包容性数字护理
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-05-27 DOI: 10.1016/j.hlpt.2025.101039
Jessica A. Coetzer , Nicole S. Goedhart , Tjerk Jan Schuitmaker-Warnaar , Christine Dedding , Teun Zuiderent-Jerak

Objectives

The digitalisation of care, whilst beneficial for some, also risks exacerbating health inequities if existing health (and social) disparities are not considered. Literature has indicated the broad, systemic causes of digital health inequities could be addressed through policy. This article aims to explore how health inequities are rendered (in)visible in and by digital care policies.

Methods

We inductively analysed sixteen Dutch health policy documents focusing on digital care. Employing a constructivist grounded theory approach, we analysed documents to determine how health equity is addressed in relation to digital care.

Results

Although Dutch health policies do consider health inequities, it is not always shown in policies as a concept related to digital care. Health policies portray digital care as progressive and innovative, being able to shape healthcare in several positive ways. The risks of digital care are attended to less, with focus being placed mostly on privacy and data-security rather than also paying attention to digital health inequities.

Conclusions

Policies either ignore digital health equity entirely or present digital health equity in ways that risk overlooking how digital care may subtly aggravate health inequities. This creates a blind spot in which technological deterministic narratives can be disguised. Current policies could unintentionally perpetuate exclusion by not highlighting the role of digital health inequities as a part of the health equity landscape. Policy needs to allow for digital health inequities to be better recognised, allowing digital care to drive, rather than limit, the possibilities for a more equitable future.

Lay Summary

Digital care is increasing in popularity, but risks excluding a significant number of people who usually already experience health inequities. Although Dutch health policy does consider health inequities, it is not shown in policies as a concept related to digital care. As a result, health equity risks being forgotten in the development of digital care. Policies portray digital care as being able to shape healthcare in a number of positive ways but do not address the risks it may pose in widening health inequities. Instead, issues like ensuring privacy receive more attention. By being overly optimistic about technology without being cautious about its other social consequences, achieving aims such as affordable and accessible care could be negatively impacted. Policy needs to allow for digital health inequities to be better recognised, allowing digital care to drive, rather than limit, the possibilities for a more equitable future.
医疗数字化虽然对一些人有益,但如果不考虑现有的健康(和社会)差距,也有加剧卫生不平等的风险。文献表明,数字卫生不平等的广泛、系统性原因可以通过政策来解决。本文旨在探讨卫生不平等是如何在数字医疗政策中显现出来的。方法对荷兰16份以数字医疗为重点的卫生政策文件进行归纳分析。采用建构主义扎根理论方法,我们分析了文献,以确定如何解决与数字医疗相关的卫生公平问题。结果虽然荷兰的卫生政策确实考虑到卫生不平等,但它并不总是作为与数字保健相关的概念显示在政策中。卫生政策将数字医疗描绘为进步和创新,能够以多种积极的方式塑造医疗保健。对数字医疗风险的关注较少,重点主要放在隐私和数据安全上,而不是关注数字医疗不平等问题。政策要么完全忽视数字健康公平,要么以忽视数字医疗如何微妙地加剧健康不平等的方式呈现数字健康公平。这就造成了一个盲点,在这个盲点中,技术决定论的叙述可以被伪装起来。目前的政策没有强调数字卫生不平等作为卫生公平格局一部分的作用,可能会无意中使排斥现象永久化。政策需要允许更好地认识到数字卫生不公平现象,使数字保健能够推动而不是限制实现更公平未来的可能性。数字医疗越来越受欢迎,但有可能将大量通常已经经历健康不平等的人排除在外。虽然荷兰的卫生政策确实考虑到卫生不公平现象,但在政策中并未将其作为与数字保健相关的概念加以体现。因此,在数字医疗的发展过程中,卫生公平有可能被遗忘。政策将数字医疗描述为能够以多种积极的方式塑造医疗保健,但没有解决它可能导致卫生不平等现象扩大的风险。相反,像确保隐私这样的问题得到了更多的关注。对技术过于乐观,而对其其他社会后果不谨慎,可能会对实现可负担和可获得的医疗服务等目标产生负面影响。政策需要允许更好地认识到数字卫生不公平现象,使数字保健能够推动而不是限制实现更公平未来的可能性。
{"title":"Health equity in the digital age: Exploring health policy and inclusive digital care","authors":"Jessica A. Coetzer ,&nbsp;Nicole S. Goedhart ,&nbsp;Tjerk Jan Schuitmaker-Warnaar ,&nbsp;Christine Dedding ,&nbsp;Teun Zuiderent-Jerak","doi":"10.1016/j.hlpt.2025.101039","DOIUrl":"10.1016/j.hlpt.2025.101039","url":null,"abstract":"<div><h3>Objectives</h3><div>The digitalisation of care, whilst beneficial for some, also risks exacerbating health inequities if existing health (and social) disparities are not considered. Literature has indicated the broad, systemic causes of digital health inequities could be addressed through policy. This article aims to explore how health inequities are rendered (in)visible in and by digital care policies.</div></div><div><h3>Methods</h3><div>We inductively analysed sixteen Dutch health policy documents focusing on digital care. Employing a constructivist grounded theory approach, we analysed documents to determine how health equity is addressed in relation to digital care.</div></div><div><h3>Results</h3><div>Although Dutch health policies do consider health inequities, it is not always shown in policies as a concept related to digital care. Health policies portray digital care as progressive and innovative, being able to shape healthcare in several positive ways. The risks of digital care are attended to less, with focus being placed mostly on privacy and data-security rather than also paying attention to digital health inequities.</div></div><div><h3>Conclusions</h3><div>Policies either ignore digital health equity entirely or present digital health equity in ways that risk overlooking how digital care may subtly aggravate health inequities. This creates a blind spot in which technological deterministic narratives can be disguised. Current policies could unintentionally perpetuate exclusion by not highlighting the role of digital health inequities as a part of the health equity landscape. Policy needs to allow for digital health inequities to be better recognised, allowing digital care to drive, rather than limit, the possibilities for a more equitable future.</div></div><div><h3>Lay Summary</h3><div>Digital care is increasing in popularity, but risks excluding a significant number of people who usually already experience health inequities. Although Dutch health policy does consider health inequities, it is not shown in policies as a concept related to digital care. As a result, health equity risks being forgotten in the development of digital care. Policies portray digital care as being able to shape healthcare in a number of positive ways but do not address the risks it may pose in widening health inequities. Instead, issues like ensuring privacy receive more attention. By being overly optimistic about technology without being cautious about its other social consequences, achieving aims such as affordable and accessible care could be negatively impacted. Policy needs to allow for digital health inequities to be better recognised, allowing digital care to drive, rather than limit, the possibilities for a more equitable future.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101039"},"PeriodicalIF":3.4,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144212820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rural digitalization and health outcomes of older adults in China 中国农村数字化与老年人健康状况
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-05-22 DOI: 10.1016/j.hlpt.2025.101038
Kunkun Duan , Jing Li
This study investigates the relationship between rural digitalization and older adults' health conditions. Drawing on the China Longitudinal Aging Social Survey 2020 data, using ordinary least squares (OLS) regression analysis, instrumental variable (IV) methods, and propensity score matching (PSM), the present study finds that rural digitalization significantly improves both physical health (β = 0.295, p < 0.001) and reduces depression propensity score (β = -1.540, p < 0.001). Moreover, the impact of rural digitalization development on older adults' health exhibits differences: older adults (80+) and those using the internet gain more benefits; there is more remarkable support for the physical health of less educated older adults, while mental health support is more pronounced for those with higher education levels. The findings underscore the potential of rural digitalization to mitigate health disparities and advocate for inclusive digital policies tailored to vulnerable older populations.
本研究探讨农村数字化与老年人健康状况的关系。利用《2020年中国老龄化纵向社会调查》数据,采用普通最小二乘(OLS)回归分析、工具变量(IV)方法和倾向得分匹配(PSM)方法,本研究发现农村数字化显著改善了农村居民的身体健康状况(β = 0.295, p <;0.001)并降低抑郁倾向评分(β = -1.540, p <;0.001)。此外,农村数字化发展对老年人健康的影响也存在差异:80岁以上老年人和使用互联网的老年人受益更多;受教育程度较低的老年人得到的身体健康支持更为显著,而受教育程度较高的老年人得到的心理健康支持更为明显。研究结果强调了农村数字化在缓解健康差距和倡导针对弱势老年人口的包容性数字政策方面的潜力。
{"title":"Rural digitalization and health outcomes of older adults in China","authors":"Kunkun Duan ,&nbsp;Jing Li","doi":"10.1016/j.hlpt.2025.101038","DOIUrl":"10.1016/j.hlpt.2025.101038","url":null,"abstract":"<div><div>This study investigates the relationship between rural digitalization and older adults' health conditions. Drawing on the China Longitudinal Aging Social Survey 2020 data, using ordinary least squares (OLS) regression analysis, instrumental variable (IV) methods, and propensity score matching (PSM), the present study finds that rural digitalization significantly improves both physical health (β = 0.295, <em>p</em> &lt; 0.001) and reduces depression propensity score (β = -1.540, <em>p</em> &lt; 0.001). Moreover, the impact of rural digitalization development on older adults' health exhibits differences: older adults (80+) and those using the internet gain more benefits; there is more remarkable support for the physical health of less educated older adults, while mental health support is more pronounced for those with higher education levels. The findings underscore the potential of rural digitalization to mitigate health disparities and advocate for inclusive digital policies tailored to vulnerable older populations.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 5","pages":"Article 101038"},"PeriodicalIF":3.4,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144147257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitating acceptance, trust, and ethical integration of socially assistive robots among nurses: A quasi-experimental study 促进护士对社会辅助机器人的接受、信任和伦理整合:一项准实验研究
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-05-20 DOI: 10.1016/j.hlpt.2025.101034
Izidor Mlakar (Dr.) , Igor Robert Roj , Vojko Flis (Dr.) , Valentino Šafran , Urška Smrke (Dr.) , Nejc Plohl (Dr.)
Objectives: To evaluate the impact of different types of demonstrations (no demonstration, video demonstration, and face-to-face demonstration) on nurses’ acceptance, trust, and ethical considerations regarding socially assistive robots.
Methods: The study employed a quasi-experimental design involving 312 nurses: 201 with no exposure to socially assistive robots, 97 exposed via video demonstrations, and 14 exposed through live face-to-face demonstrations in a hospital room. Participants completed self-report measures assessing their perceptions of ethical acceptability, trust, and acceptance of socially assistive robots.
Results: Participants exposed to any kind of demonstration reported significantly higher perceptions of ethical acceptability compared to those with no exposure. Among demonstration types, live face-to-face demonstrations resulted in higher overall ethical acceptability, satisfaction, and acceptance compared to video demonstrations.
Conclusions: Demonstrations, particularly face-to-face interactions, play a crucial role in fostering ethical acceptability and overall acceptance of socially assistive robots. These findings highlight the importance of incorporating live demonstrations in strategies to improve healthcare professionals’ trust and acceptance of robotic technology.
目的:评估不同类型的演示(无演示、视频演示和面对面演示)对护士对社交辅助机器人的接受度、信任度和伦理考虑的影响。方法:本研究采用准实验设计,涉及312名护士:201名未接触社交辅助机器人,97名通过视频演示,14名通过病房现场面对面演示。参与者完成了自我报告测量,评估他们对社会辅助机器人的道德可接受性、信任和接受度的看法。结果:与没有接触的参与者相比,接触任何形式的演示的参与者报告了明显更高的道德可接受性观念。在演示类型中,与视频演示相比,现场面对面演示的总体道德可接受性、满意度和接受度更高。结论:演示,特别是面对面的互动,在促进社会辅助机器人的道德接受度和整体接受度方面发挥着至关重要的作用。这些发现强调了将现场演示纳入提高医疗保健专业人员对机器人技术的信任和接受度的战略的重要性。
{"title":"Facilitating acceptance, trust, and ethical integration of socially assistive robots among nurses: A quasi-experimental study","authors":"Izidor Mlakar (Dr.) ,&nbsp;Igor Robert Roj ,&nbsp;Vojko Flis (Dr.) ,&nbsp;Valentino Šafran ,&nbsp;Urška Smrke (Dr.) ,&nbsp;Nejc Plohl (Dr.)","doi":"10.1016/j.hlpt.2025.101034","DOIUrl":"10.1016/j.hlpt.2025.101034","url":null,"abstract":"<div><div>Objectives: To evaluate the impact of different types of demonstrations (no demonstration, video demonstration, and face-to-face demonstration) on nurses’ acceptance, trust, and ethical considerations regarding socially assistive robots.</div><div>Methods: The study employed a quasi-experimental design involving 312 nurses: 201 with no exposure to socially assistive robots, 97 exposed via video demonstrations, and 14 exposed through live face-to-face demonstrations in a hospital room. Participants completed self-report measures assessing their perceptions of ethical acceptability, trust, and acceptance of socially assistive robots.</div><div>Results: Participants exposed to any kind of demonstration reported significantly higher perceptions of ethical acceptability compared to those with no exposure. Among demonstration types, live face-to-face demonstrations resulted in higher overall ethical acceptability, satisfaction, and acceptance compared to video demonstrations.</div><div>Conclusions: Demonstrations, particularly face-to-face interactions, play a crucial role in fostering ethical acceptability and overall acceptance of socially assistive robots. These findings highlight the importance of incorporating live demonstrations in strategies to improve healthcare professionals’ trust and acceptance of robotic technology.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101034"},"PeriodicalIF":3.4,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144137686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
S.A.R.A.H. and the decline of trust in health information: a case study s.a.a.h.与健康信息信任度下降:一个案例研究
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-05-18 DOI: 10.1016/j.hlpt.2025.101032
Federico Germani, Giovanni Spitale, Nikola Biller-Andorno
This case study critically examines S.A.R.A.H. (Smart AI Resource Assistant for Health) as an element of the World Health Organization's (WHO) digital health strategy, focusing on its design and generated content. Launched in April 2024 to provide accessible health information and combat misinformation, S.A.R.A.H. utilizes generative AI to engage users across diverse health topics. Despite its purported empathetic design, concerns arise regarding its operational functionality and empathetic capabilities. By critically analyzing S.A.R.A.H.'s operational limitations and discussing the implications for trust, this paper highlights the tool's potential to erode public trust in WHO as a reliable health information source. It also identifies potential strategies for the development and release of similar tools. The paper underscores the importance of ethical considerations and operational effectiveness in deploying digital health initiatives, aiming to inform future strategies in AI integration within public health. Ultimately, it emphasizes the critical need to uphold trust and credibility in global health institutions.
本案例研究将sara(卫生智能人工智能资源助理)作为世界卫生组织(世卫组织)数字卫生战略的一个组成部分进行了严格审查,重点关注其设计和生成的内容。S.A.R.A.H.于2024年4月启动,旨在提供可获取的卫生信息和打击错误信息,利用生成式人工智能吸引不同卫生主题的用户。尽管它有所谓的移情设计,但它的操作功能和移情能力引起了人们的关注。通过批判性地分析莎拉鉴于该工具的操作局限性,并讨论了其对信任的影响,本文强调了该工具有可能削弱公众对世卫组织作为可靠卫生信息来源的信任。它还确定了开发和发布类似工具的潜在策略。该文件强调了在部署数字卫生举措时伦理考虑和业务有效性的重要性,旨在为公共卫生领域人工智能整合的未来战略提供信息。最后,它强调必须维护全球卫生机构的信任和信誉。
{"title":"S.A.R.A.H. and the decline of trust in health information: a case study","authors":"Federico Germani,&nbsp;Giovanni Spitale,&nbsp;Nikola Biller-Andorno","doi":"10.1016/j.hlpt.2025.101032","DOIUrl":"10.1016/j.hlpt.2025.101032","url":null,"abstract":"<div><div>This case study critically examines S.A.R.A.H. (Smart AI Resource Assistant for Health) as an element of the World Health Organization's (WHO) digital health strategy, focusing on its design and generated content. Launched in April 2024 to provide accessible health information and combat misinformation, S.A.R.A.H. utilizes generative AI to engage users across diverse health topics. Despite its purported empathetic design, concerns arise regarding its operational functionality and empathetic capabilities. By critically analyzing S.A.R.A.H.'s operational limitations and discussing the implications for trust, this paper highlights the tool's potential to erode public trust in WHO as a reliable health information source. It also identifies potential strategies for the development and release of similar tools. The paper underscores the importance of ethical considerations and operational effectiveness in deploying digital health initiatives, aiming to inform future strategies in AI integration within public health. Ultimately, it emphasizes the critical need to uphold trust and credibility in global health institutions.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101032"},"PeriodicalIF":3.4,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Policy and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1